<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>LA-MARRVEL: A Knowledge-Grounded and Language-Aware LLM Reranker for AI-MARRVEL in Rare Disease Diagnosis - Health AI Hub</title>
    <meta name="description" content="LA-MARRVEL introduces a knowledge-grounded and language-aware Large Language Model (LLM) reranking layer for AI-MARRVEL, designed to improve rare disease diagno">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>LA-MARRVEL: A Knowledge-Grounded and Language-Aware LLM Reranker for AI-MARRVEL in Rare Disease Diagnosis</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02263v1" target="_blank">2511.02263v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jaeyeon Lee, Hyun-Hwan Jeong, Zhandong Liu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.GN, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02263v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02263v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">LA-MARRVEL introduces a knowledge-grounded and language-aware Large Language Model (LLM) reranking layer for AI-MARRVEL, designed to improve rare disease diagnosis by enhancing gene prioritization. It leverages expert-engineered context and multiple LLM queries to produce stable, explainable gene rankings that consistently outperform existing tools. This system significantly improves recall, particularly for challenging cases, and provides interpretable reasoning to aid clinical review.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research directly tackles a major challenge in rare disease diagnostics by automating and significantly improving the accuracy and interpretability of gene prioritization. By reducing the manual burden and enhancing diagnostic certainty, LA-MARRVEL has the potential to shorten the diagnostic odyssey for rare disease patients and enable earlier, more effective interventions.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>LA-MARRVEL is an AI-powered diagnostic support tool for rare genetic diseases. It leverages Large Language Models (LLMs) to create a 'knowledge-grounded and language-aware reranking layer' that enhances the accuracy and interpretability of gene rankings. This application aims to assist clinicians in identifying causal genes by integrating various forms of clinical and genetic evidence, ultimately improving the efficiency and reliability of rare disease diagnosis.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical bottleneck in rare disease diagnosis where variant-bearing genes must be manually linked to unstructured clinical evidence.</li>
                    
                    <li>Introduces LA-MARRVEL as an LLM-powered reranking layer that operates on top of the established AI-MARRVEL pipeline.</li>
                    
                    <li>Methodology involves supplying expert-engineered context to the LLM, querying it multiple times, and aggregating the resulting partial rankings using a ranked voting method to ensure stability.</li>
                    
                    <li>Evaluated on three real-world cohorts (BG, DDD, UDN), LA-MARRVEL consistently demonstrated improved Recall@K compared to both the base AI-MARRVEL system and other phenotype-driven tools like Exomiser and LIRICAL.</li>
                    
                    <li>Showed particularly significant gains in cases where the initial AI-MARRVEL ranker had placed the causal gene lower, indicating its effectiveness in refining challenging diagnoses.</li>
                    
                    <li>Generates LLM-based reasoning for each ranked gene, integrating multi-modal evidence including phenotypic, inheritance patterns, and variant-level information.</li>
                    
                    <li>The enhanced interpretability and comprehensive reasoning facilitate and expedite clinical review, making the diagnostic process more efficient and reliable.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>LA-MARRVEL functions as a post-processing reranking layer for AI-MARRVEL. It incorporates expert-engineered contextual information and iteratively queries a large language model (LLM). The partial rankings generated by the LLM from these multiple queries are then consolidated using a ranked voting method to produce a final, stable, and explainable gene ranking.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>LA-MARRVEL consistently improved Recall@K across three diverse real-world cohorts (BG, DDD, UDN) when compared to AI-MARRVEL and established phenotype-driven tools such as Exomiser and LIRICAL. The system showed particularly strong performance gains in cases where the initial AI-MARRVEL ranking of the causal gene was low. Additionally, LA-MARRVEL provides LLM-generated reasoning that integrates phenotypic, inheritance, and variant-level evidence for each ranked gene, enhancing interpretability.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The increased accuracy and improved Recall@K, especially for difficult diagnostic cases, will lead to faster and more confident identification of causal genes in rare diseases. The provision of LLM-generated, integrated reasoning will empower clinicians with transparent and interpretable diagnostic support, streamlining the clinical review process and potentially reducing misdiagnosis rates and diagnostic delays for rare disease patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly mention any specific limitations or caveats of the LA-MARRVEL system.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions for LA-MARRVEL.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Rare Disease</span>
                    
                    <span class="tag">Clinical Genomics</span>
                    
                    <span class="tag">Medical Genetics</span>
                    
                    <span class="tag">Diagnostic Medicine</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Rare Disease Diagnosis</span>
                    
                    <span class="tag tag-keyword">Large Language Models</span>
                    
                    <span class="tag tag-keyword">Gene Reranking</span>
                    
                    <span class="tag tag-keyword">AI-MARRVEL</span>
                    
                    <span class="tag tag-keyword">Phenotype-Driven Analysis</span>
                    
                    <span class="tag tag-keyword">Genomic Variants</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                    <span class="tag tag-keyword">Explainable AI</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Diagnosing rare diseases often requires connecting variant-bearing genes to
evidence that is written as unstructured clinical prose, which the current
established pipelines still leave for clinicians to reconcile manually. To this
end, we introduce LA-MARRVEL, a knowledge-grounded and language-aware reranking
layer that operates on top of AI-MARRVEL: it supplies expert-engineered
context, queries a large language model multiple times, and aggregates the
resulting partial rankings with a ranked voting method to produce a stable,
explainable gene ranking. Evaluated on three real-world cohorts (BG, DDD, UDN),
LA-MARRVEL consistently improves Recall@K over AI-MARRVEL and established
phenotype-driven tools such as Exomiser and LIRICAL, with especially large
gains on cases where the first-stage ranker placed the causal gene lower. Each
ranked gene is accompanied by LLM-generated reasoning that integrates
phenotypic, inheritance, and variant-level evidence, thereby making the output
more interpretable and facilitating clinical review.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>